4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol

C122H261N17O6 — CID 160974894

IUPAC4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol
SMILESCC(C)CCCCN1CCCC1.CC(C)CCCCN1CCCCC1.CC(C)CCCCN1CCN(C)CC1.CC(C)CCCCN1CCN(CCO)CC1.CC(C)CCCCN1CCOCC1.CC(C)CCCN1CCN(C)CC1.CC(C)CCCN1CCN(CCO)CC1.CC(C)CCCN1CCOCC1.CC(C)CCN1CCN(C)CC1.CC(C)CCN1CCN(CCO)CC1.CC(C)CCN1CCOCC1
InChIInChI=1S/C13H28N2O.C12H26N2O.C12H26N2.C12H25N.C11H24N2O.C11H24N2.C11H23NO.C11H23N.C10H22N2.C10H21NO.C9H19NO/c1-13(2)5-3-4-6-14-7-9-15(10-8-14)11-12-16;1-12(2)4-3-5-13-6-8-14(9-7-13)10-11-15;1-12(2)6-4-5-7-14-10-8-13(3)9-11-14;1-12(2)8-4-7-11-13-9-5-3-6-10-13;1-11(2)3-4-12-5-7-13(8-6-12)9-10-14;1-11(2)5-4-6-13-9-7-12(3)8-10-13;1-11(2)5-3-4-6-12-7-9-13-10-8-12;1-11(2)7-3-4-8-12-9-5-6-10-12;1-10(2)4-5-12-8-6-11(3)7-9-12;1-10(2)4-3-5-11-6-8-12-9-7-11;1-9(2)3-4-10-5-7-11-8-6-10/h13,16H,3-12H2,1-2H3;12,15H,3-11H2,1-2H3;12H,4-11H2,1-3H3;12H,3-11H2,1-2H3;11,14H,3-10H2,1-2H3;11H,4-10H2,1-3H3;11H,3-10H2,1-2H3;11H,3-10H2,1-2H3;10H,4-9H2,1-3H3;10H,3-9H2,1-2H3;9H,3-8H2,1-2H3
InChIKeySYSOJPKKCIVDLT-UHFFFAOYSA-N
MW2062.54 g/mol
LogP19.58
Rot. Bonds52

About 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol

4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol (PubChem CID 160974894) has the molecular formula C122H261N17O6 and a molecular weight of 2062.54 g/mol. Its IUPAC name is 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol.

Molecular Properties

Compound Name4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol
PubChem CID160974894
Molecular FormulaC122H261N17O6
Molecular Weight2062.54 g/mol
Exact Mass2061.06
IUPAC Name4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol
SMILESCC(C)CCCCN1CCCC1.CC(C)CCCCN1CCCCC1.CC(C)CCCCN1CCN(C)CC1.CC(C)CCCCN1CCN(CCO)CC1.CC(C)CCCCN1CCOCC1.CC(C)CCCN1CCN(C)CC1.CC(C)CCCN1CCN(CCO)CC1.CC(C)CCCN1CCOCC1.CC(C)CCN1CCN(C)CC1.CC(C)CCN1CCN(CCO)CC1.CC(C)CCN1CCOCC1
InChIInChI=1S/C13H28N2O.C12H26N2O.C12H26N2.C12H25N.C11H24N2O.C11H24N2.C11H23NO.C11H23N.C10H22N2.C10H21NO.C9H19NO/c1-13(2)5-3-4-6-14-7-9-15(10-8-14)11-12-16;1-12(2)4-3-5-13-6-8-14(9-7-13)10-11-15;1-12(2)6-4-5-7-14-10-8-13(3)9-11-14;1-12(2)8-4-7-11-13-9-5-3-6-10-13;1-11(2)3-4-12-5-7-13(8-6-12)9-10-14;1-11(2)5-4-6-13-9-7-12(3)8-10-13;1-11(2)5-3-4-6-12-7-9-13-10-8-12;1-11(2)7-3-4-8-12-9-5-6-10-12;1-10(2)4-5-12-8-6-11(3)7-9-12;1-10(2)4-3-5-11-6-8-12-9-7-11;1-9(2)3-4-10-5-7-11-8-6-10/h13,16H,3-12H2,1-2H3;12,15H,3-11H2,1-2H3;12H,4-11H2,1-3H3;12H,3-11H2,1-2H3;11,14H,3-10H2,1-2H3;11H,4-10H2,1-3H3;11H,3-10H2,1-2H3;11H,3-10H2,1-2H3;10H,4-9H2,1-3H3;10H,3-9H2,1-2H3;9H,3-8H2,1-2H3
InChIKeySYSOJPKKCIVDLT-UHFFFAOYSA-N
XLogP19.58
TPSA143.46 Ų
H-Bond Donors3
H-Bond Acceptors23
Rotatable Bonds52
Heavy Atoms145
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002062.54
LogP ≤ 519.58
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

formic acid;4-(4-methylpentyl)morpholine
CID 172564161
5-[4-(3-methylbutyl)piperazin-1-yl]pentan-1-ol
CID 110923815
1-methyl-4-(4-piperidin-1-ylbutyl)piperazine
CID 54547768
(3S)-3-methyl-6-morpholin-4-ylhexan-1-ol
CID 174809295
ethane;3-ethyl-7-morpholin-4-ylheptan-1-ol
CID 144711905
4-(4-methylpentyl)morpholine;N,N,2-trimethylpropan-1-amine
CID 142615810
(3R)-7-morpholin-4-yl-3-propylheptan-1-ol
CID 118890062
4-[2-(4-methylpiperazin-1-yl)ethyl]morpholine
CID 20719664
N-methyl-6-(1,4-oxazepan-4-yl)hexan-2-amine
CID 62987109
2-(4-methylpiperazin-1-yl)ethanamine;2-morpholin-4-ylethanamine;2-piperidin-1-ylethanamine
CID 162033952
ethane;4-morpholin-4-ylbutan-1-ol
CID 162683886
2-morpholin-4-ylethanol;2-piperazin-1-ylethanol;2-piperidin-1-ylethanol;2-pyrrolidin-1-ylethanol
CID 157451778

Frequently Asked Questions

What is the IUPAC name of 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol?
The IUPAC name of 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol (CID 160974894) is 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol.
What is the SMILES notation for 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol?
The canonical SMILES for 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol is CC(C)CCCCN1CCCC1.CC(C)CCCCN1CCCCC1.CC(C)CCCCN1CCN(C)CC1.CC(C)CCCCN1CCN(CCO)CC1.CC(C)CCCCN1CCOCC1.CC(C)CCCN1CCN(C)CC1.CC(C)CCCN1CCN(CCO)CC1.CC(C)CCCN1CCOCC1.CC(C)CCN1CCN(C)CC1.CC(C)CCN1CCN(CCO)CC1.CC(C)CCN1CCOCC1.
What is the InChIKey of 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol?
The InChIKey is SYSOJPKKCIVDLT-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H28N2O.C12H26N2O.C12H26N2.C12H25N.C11H24N2O.C11H24N2.C11H23NO.C11H23N.C10H22N2.C10H21NO.C9H19NO/c1-13(2)5-3-4-6-14-7-9-15(10-8-14)11-12-16;1-12(2)4-3-5-13-6-8-14(9-7-13)10-11-15;1-12(2)6-4-5-7-14-10-8-13(3)9-11-14;1-12(2)8-4-7-11-13-9-5-3-6-10-13;1-11(2)3-4-12-5-7-13(8-6-12)9-10-14;1-11(2)5-4-6-13-9-7-12(3)8-10-13;1-11(2)5-3-4-6-12-7-9-13-10-8-12;1-11(2)7-3-4-8-12-9-5-6-10-12;1-10(2)4-5-12-8-6-11(3)7-9-12;1-10(2)4-3-5-11-6-8-12-9-7-11;1-9(2)3-4-10-5-7-11-8-6-10/h13,16H,3-12H2,1-2H3;12,15H,3-11H2,1-2H3;12H,4-11H2,1-3H3;12H,3-11H2,1-2H3;11,14H,3-10H2,1-2H3;11H,4-10H2,1-3H3;11H,3-10H2,1-2H3;11H,3-10H2,1-2H3;10H,4-9H2,1-3H3;10H,3-9H2,1-2H3;9H,3-8H2,1-2H3.
What are the key properties of 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol?
4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol has a molecular weight of 2062.54 g/mol, XLogP of 19.58, 52 rotatable bonds, 3 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(3-methylbutyl)morpholine;2-[4-(3-methylbutyl)piperazin-1-yl]ethanol;4-(5-methylhexyl)morpholine;2-[4-(5-methylhexyl)piperazin-1-yl]ethanol;1-(5-methylhexyl)piperidine;1-(5-methylhexyl)pyrrolidine;1-methyl-4-(3-methylbutyl)piperazine;1-methyl-4-(5-methylhexyl)piperazine;1-methyl-4-(4-methylpentyl)piperazine;4-(4-methylpentyl)morpholine;2-[4-(4-methylpentyl)piperazin-1-yl]ethanol is sourced from PubChem (CID 160974894), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).